Syntara Limited (ASX:SNT)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
New Drug Development	6.93M	7.30M	5.76M	6.23M	5.68M
Mannitol Respiratory Business	-	-	-	-	9.77M
Corporate	-	-	-	-	308.00K
Total	6.93M	7.30M	5.76M	6.23M	15.76M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Australia	917.00K
Western Europe	790.00K
Europe	770.00K
USA & Canada	334.00K
South Korea	267.00K
Central and Eastern Europe	506.00K
Russia	2.23M
United States	1.62M
Total	7.43M

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 7, 2026

Data Sources Report a data error